11.26.24 -- Portals For Productive Communication

Our panelists combine their lists for the top criteria when determining which CDMO is the best fit for your program specifically and your organization overall.

There are certain roles that must be filled before you move into manufacturing to avoid costly delays and incur non-value-added expenses. Discover what those roles are and get ideas on how to fill them.

It is crucial to monitor the IP landscape and file patent applications for advancements. By staying informed and proactive, companies can secure their position in the rapidly evolving CGT field.

Ensure a smooth and efficient technology transfer by following key strategies and avoiding common pitfalls to streamline your process and achieve consistent, error-free results.

Uncover how autologous cell therapy clinical trial protocol designs can greatly benefit from the inclusion of multifunctional, multi-departmental stakeholders’ input and feedback.

To ensure the success of gene therapy, learn why it is crucial to partner with a CRO that can navigate the challenges of viral vector development and testing.

Discover why manufacturers must adopt more consumer-centric recall strategies to maintain trust and safeguard their market position.

An integrated approach to mRNA drug product manufacturing helps to accelerate drug development, mitigate risks, and ultimately deliver life-changing therapies to patients.

As mRNA medicine continues to evolve, understand how trusted manufacturing partners will continue to play a pivotal role in translating innovative concepts into clinical reality.

Examine the post-thaw segment QC results for 2,249 consecutive segments cut at our institution, in order to create a benchmark of what is to be expected when interpreting segment testing.

Optimize your mRNA production with an advanced IVT process, enhancing scalability, purity, and expression activity for clinically relevant RNA therapeutics.

Explore the key aspects of lipid nanoparticle (LNP) development, including the essential downstream processes of Tangential Flow Filtration (TFF) and normal flow filtration.

Here, we describe research grade and process development productions of rAAV6, both based on transient transfection of serum-free cells grown in suspension.

An industry expert shares about sustainable Oligo manufacturing approaches that can save time, cost, and resources – while improving purity, quality, and scalability of these promising therapeutics.

Xcite® AAV Platform Technology is established based on our proprietary suspension HEK293 cell line and plasmid vectors, proven to enhance AAV production.

With our global network of facilities and services, Cryoport Systems is a strategic partner of choice for temperature-controlled supply chain management of critical materials.

See how our end-to-end, customer-centric CDMO services are helping to bring more breakthrough treatments to patients.

Whether you are looking to optimize your existing formulations or require full-scale manufacturing solutions, we're dedicated to realizing your vision and delivering impactful therapies.

Our pharmaceutical packaging design department provides insightful packaging design and practical knowledge to deliver differentiated and cost-effective packaging solutions.